Clinical Trial Update: A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This update describes a Phase Ib/II study evaluating linperlisib in combination with the VRD regimen for newly diagnosed multiple myeloma, which is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Linperlisib (linperlisib)

Snippet

Sponsor: Fuling Zhou | Conditions: Newly Diagnosed Multiple Myeloma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING